[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368273-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368273-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pathogenic-variants-in-brca1-and-brca2-genes-associated-with-female-breast-and-ovarian-cancer-in-the-mexican-population","Pathogenic variants in BRCA1 and BRCA2 genes associated with female breast and ovarian cancer in the Mexican population","","Breast and ovarian cancers pose major global health burdens, and inherited alterations in breast cancer gene 1 (BRCA1) and breast cancer gene 2 (BRCA2) markedly increase risk, aggressiveness, and earlier onset. The study analyzed pathogenic variants in BRCA1 and BRCA2 databases that include Mexican cohorts using systematic review and data mining from 2002 to 2023. Databases were standardized and enriched from multiple reputable genomic platforms to produce findings from 9,026 Mexican genotypes, identifying 657 pathogenic variants, with hotspot exons and a founder-effect-associated BRCA1 deletion.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pathogenic-variants-in-brca1-and-brca2-genes-associated-with-female-breast-and-ovarian-cancer-in-the-mexican-population/368273/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pathogenic-variants-in-brca1-and-brca2-genes-associated-with-female-breast-and-ovarian-cancer-in-the-mexican-population/368273.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the goal of analyzing BRCA1 and BRCA2 in Mexican populations?","Question",{"text":63,"@type":64},"To examine pathogenic variants in BRCA1 and BRCA2 databases that include Mexican cohorts, identifying variants linked to female breast and ovarian cancer risk.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were pathogenic variants collected and verified?",{"text":68,"@type":64},"A systematic review and data mining process from 2002 to 2023 was performed, screening journal articles and enriching paired databases with data from established global genomic resources.",{"name":70,"@type":61,"acceptedAnswer":71},"Which BRCA regions and variant types were highlighted as most important?",{"text":72,"@type":64},"Genetic mapping indicated highly mutagenic hotspot exons, notably exon 10 of BRCA1 and exon 11 of BRCA2, and the most frequent alteration was a large BRCA1 deletion (ex9-12del) associated with a founder effect.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368273,1790199819,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","JOURNAL of MEDICINE and LIFE  \nJML | ORIGINAL ARTICLE  \nPathogenic variants in BRCA1 and BRCA2 genes associated with female breast and ovarian cancer in the Mexican population  \nFlor Daniela Alday-Montañez1 , Daniel Dickens-Terrazas2, Gloria Erika Mejia-Carmona1  , Elisa Robles-Escajeda3  , Robert Arthur Kirken3  , Alfonso Enrique Bencomo-Alvarez4  , Victor Josue Carrasco-Urrutia5, Naun Lobo-Galo1  , Luis Fernando Plenge-Tellechea1  , Ángel Gabriel Diaz-Sanchez1 , Alejandro Martínez-Martínez1*  \n1. Department of Chemical-Biological Sciences, Autonomous University of Ciudad Juarez, Ciudad Juarez, Chihuahua, Mexico  \n2. IMSS, Zone Hospital Number 6, Ciudad Juarez, Chihuahua, Mexico  \n3. Department of Biological Sciences, The Border Biomedical Research Center, The Cellular Characterization and Biorepository Core Facility, The University of Texas, El Paso, Texas, USA  \n4. Department of Host-Microbe Interactions, St. Jude Children’s Research Hospital, Memphis, TN, USA  \n5. Endofem, Ciudad Juarez, Chihuahua, Mexico  \n* Corresponding author  \nAlejandro Martínez-Martínez  \nDepartment of Chemical-Biological Sciences, Autonomous University of Ciudad Juarez, Ciudad Juarez, Chihuahua, Mexico  \nE-mail: [alejandro. martinez@uacj. mx](alejandro. martinez@uacj. mx)  \nDOI  \n10.25122/jml-2024-0213  \nDates  \nReceived: 2 May 2024  \nAccepted: 30 September 2024  \nABSTRACT  \nBreast and ovarian cancers are significant global health challenges, with inherited variations in breast cancer gene  \n1 (BRCA1) and breast cancer gene 2 (BRCA2) substantially increasing the risk, aggressiveness, and early onset of these diseases. This work aimed to examine pathogenic variants (PVs) in BRCA1 and BRCA2 databases that include Mexican populations. A systematic review of literature and data mining spanning from 2002 to 2023 was conducted. Articles published in journals indexed in SCImago quartiles Q1 to Q4 were screened. Databases were paired, standardized, and enriched with data from reputable global platforms: Genome Data Viewer, dbSNP, ClinVar, gnomAD browser, Breast Cancer Information Core (BIC), ClinGen, Varsome, Human Genome Variation Society (HGVS), Bioproject, Ensembl, Gene NIH NCIB, UniProt, and BRCA Exchange. Outcomes included data from 9,026 Mexican genotypes, identifying 657 PVs. Genetic mapping revealed certain exons, notably exon 10 of BRCA1 and exon  \n11 of BRCA2, as highly mutagenic hot spots. The most frequent alteration was a large deletion in BRCA1 (ex9-12del), associated with a founder effect originating from a common Mexican ancestor. Finally, we constructed a genetic map containing all the single nucleotide variants (SNVs) and large rearrangements presented in the analyzed databases. KEYWORDS: founder effect, Mexican population, breast cancer, ovarian cancer, genetic variation ABBREVIATIONS: BC, Breast cancer; OC, ovarian cancer; HBOC, hereditary breast and ovarian cancer syndrome (HBOC); BRCA1, Breast Cancer Susceptibility Gene 1; BRCA2, Breast Cancer Susceptibility Gene 2; HRR, Homologous Recombination Repair pathway; PALB2, Partner and Localizer of BRCA2; RAD-51, DNA repair protein RAD-51 homolog 1; BARD1, BRCA1-associated RING domain protein-1; TNBC, triple-negative breast cancer; CR, mutation-specific cluster regions; SNVs, Single Nucleotide variants; TCGA, The Cancer Genome Atlas; MLPA, multiplex ligation-dependent probe amplification  \nINTRODUCTION  \nBreast and ovarian cancer syndrome (HBOC), linked to inherited variations, presents significant challenges in women's health worldwide [1] . Breast cancer (BC) is particularly pervasive, accounting for the highest number of new cancer cases among women globally. In 2022 alone, 2.3 million women were diagnosed with BC, leading to 666,103 deaths and making it the main cause of cancer-related mortality in women worldwide.  \nConversely, ovarian cancer (OC) ranks as the sixth most common gynecologic cancer but carries the highest mortality rate among these cancers [2] . Despite its lower prevalen","cbCaiu0FuPdlwASn","https://ap.wps.com/l/cbCaiu0FuPdlwASn","pdf",1094265,"English","# Abstract\n# Introduction\n## Breast cancer and ovarian cancer burden\n## Inherited variations and the role of BRCA1/BRCA2\n# Methods\n## Systematic review and data mining (2002-2023)\n## Database pairing, standardization, and enrichment\n# Results\n## Mexican genotype dataset and pathogenic variant identification\n## Mutagenic hotspots and founder-effect deletion\n## Genetic map of SNVs and large rearrangements","[{\"question\":\"What was the goal of analyzing BRCA1 and BRCA2 in Mexican populations?\",\"answer\":\"To examine pathogenic variants in BRCA1 and BRCA2 databases that include Mexican cohorts, identifying variants linked to female breast and ovarian cancer risk.\"},{\"question\":\"How were pathogenic variants collected and verified?\",\"answer\":\"A systematic review and data mining process from 2002 to 2023 was performed, screening journal articles and enriching paired databases with data from established global genomic resources.\"},{\"question\":\"Which BRCA regions and variant types were highlighted as most important?\",\"answer\":\"Genetic mapping indicated highly mutagenic hotspot exons, notably exon 10 of BRCA1 and exon 11 of BRCA2, and the most frequent alteration was a large BRCA1 deletion (ex9-12del) associated with a founder effect.\"}]","Pathogenic variants in BRCA1 and BRCA2 genes associated with female breast and ovarian cancer in the Mexican population | PDF",1790175975,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bc820e17459aab38dfe41644afc37fe7.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b75befaa2e4aba9d8514365f1ac3a8a.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ca224340d2f2a1a143adccfa846097a.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9c53f46d9414d99f47f9626e7ed9102.webp",980,1385]